Literature DB >> 34845629

Gestational chronic intermittent hypoxia induces hypertension, proteinuria, and fetal growth restriction in mice.

Cuilian Weng1, Long Huang1, Hangwei Feng1, Quanying He2, Xingsheng Lin1, Tingting Jiang3, Jian Lin1, Xincai Wang1, Qinghua Liu4.   

Abstract

PURPOSE: Pregnant women are predisposed to obstructive sleep apnea (OSA). Based on the fact that OSA is an independent risk factor for hypertension among the general population, we hypothesized that chronic intermittent hypoxia (CIH), as a feature of OSA, may lead to preeclampsia.
METHODS: Pregnant and non-pregnant C57BL/6 J mice were exposed to two conditions of chronic intermittent hypoxia: CIH1 (21-5% O2 alternations), CIH2 (21-10% O2 alternations), and room air until day 19.
RESULTS: In non-pregnant mice, compared with their respective baseline values, systolic blood pressure (SBP) started to rise from day 14 in the CIH1 group, and SBP rose until day 19 in the CIH2 group. Compared with the pregnant mice exposed to room air, pregnant mice exposed to CIH1 maintained elevated SBP from day 14, accompanied by proteinuria, fetal and placental growth restriction, and a reduction in the number of fetuses. An imbalance between proangiogenic and antiangiogenic factors and impairment of vascular remodeling existed in the placenta of pregnant mice exposed to CIH1. Maternal serum levels of the soluble form of vascular endothelial growth factor receptor-1 were also significantly increased. Pregnant mice exposed to CIH2 seemed to have milder changes than pregnant mice exposed to CIH1.
CONCLUSION: Our results demonstrated that gestational CIH may induce gestational hypertension, proteinuria, fetal and placental growth restriction as well as impairments in placental angiogenesis and vascular remodeling.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Intermittent hypoxia; Obstructive; Preeclampsia; Sleep apnea

Year:  2021        PMID: 34845629     DOI: 10.1007/s11325-021-02529-3

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  2 in total

Review 1.  Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis.

Authors:  Carmen Stanca Melincovici; Adina Bianca Boşca; Sergiu Şuşman; Mariana Mărginean; Carina Mihu; Mihnea Istrate; Ioana Maria Moldovan; Alexandra Livia Roman; Carmen Mihaela Mihu
Journal:  Rom J Morphol Embryol       Date:  2018       Impact factor: 1.033

2.  Sulfated glycans engage the Ang-Tie pathway to regulate vascular development.

Authors:  Alexander W Sorum; Gregory M Miller; Matthew E Griffin; William A Goddard; Linda C Hsieh-Wilson
Journal:  Nat Chem Biol       Date:  2020-10-05       Impact factor: 15.040

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.